Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats
- 31 March 1993
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 44 (4-6) , 677-680
- https://doi.org/10.1016/0960-0760(93)90280-a
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumoursEuropean Journal of Cancer and Clinical Oncology, 1991
- Novel Irreversible Aromatase InhibitorsAnnals of the New York Academy of Sciences, 1990
- Effect of CGS 16949A plus tamoxifen on induced mammary tumours in ratsEuropean Journal of Cancer and Clinical Oncology, 1990
- A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumorsCancer Chemotherapy and Pharmacology, 1989
- 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitorJournal of Steroid Biochemistry, 1988
- An evaluation of tamoxifen as a partial agonist by classical receptor theory — An explanation of the dual action of tamoxifenEuropean Journal of Pharmacology, 1984